Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Mallinckrodt
Dow
Express Scripts
AstraZeneca

Last Updated: November 27, 2022

Ceftriaxone sodium - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic drug sources for ceftriaxone sodium and what is the scope of freedom to operate?

Ceftriaxone sodium is the generic ingredient in seven branded drugs marketed by Acs Dobfar, Agila Speclts, Atlantide, Aurobindo Pharma Ltd, Bedford, Facta Farma, Fresenius Kabi Usa, Hospira Inc, Lupin, Qilu, Samson Medcl, Sandoz, Sandoz Inc, Teva, B Braun, Baxter Hlthcare, Astral, Hikma, Hoffmann La Roche, Roche, Akorn, Cephazone Pharma, Hikma Farmaceutica, and Teva Pharms Usa, and is included in forty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-five drug master file entries for ceftriaxone sodium. Nineteen suppliers are listed for this compound.

Summary for ceftriaxone sodium
Recent Clinical Trials for ceftriaxone sodium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Johns Hopkins All Children's HospitalPhase 2
M.D. Anderson Cancer CenterPhase 2
The Grant Medical College & Sir J.J. Group of HospitalsPhase 4

See all ceftriaxone sodium clinical trials

Pharmacology for ceftriaxone sodium
Medical Subject Heading (MeSH) Categories for ceftriaxone sodium

US Patents and Regulatory Information for ceftriaxone sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cephazone Pharma CEFTRIAXONE ceftriaxone sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 065294-004 Mar 26, 2007 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Facta Farma CEFTRIAXONE ceftriaxone sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 065268-001 Feb 28, 2007 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Astral CEFTRIAXONE SODIUM ceftriaxone sodium INJECTABLE;INJECTION 091117-001 Jan 20, 2017 AP RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Aurobindo Pharma Ltd CEFTRIAXONE ceftriaxone sodium INJECTABLE;INJECTION 065504-001 Jul 31, 2008 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Hospira Inc CEFTRIAXONE ceftriaxone sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 065230-002 Aug 2, 2005 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Bedford CEFTRIAXONE ceftriaxone sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 065465-002 Aug 18, 2008 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Dow
Express Scripts
Colorcon
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.